Literature DB >> 18272712

Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence.

O J Strauss1, R M Warren, A Jordaan, E M Streicher, M Hanekom, A A Falmer, H Albert, A Trollip, E Hoosain, P D van Helden, T C Victor.   

Abstract

The fitness cost associated with the evolution of resistance to rifampin in Mycobacterium tuberculosis may be different in clinical isolates compared to in vitro-generated mutants. An atypical Beijing strain (attenuated phenotype) demonstrated the ability to spread despite acquiring resistance to rifampin. Transmission was linked to human immunodeficiency virus coinfection (P = 0.029), raising concern for the spread of drug resistance in vulnerable populations.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18272712      PMCID： PMC2292903          DOI： 10.1128/JCM.01938-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains.

Authors:  Pablo J Bifani; Barun Mathema; Natalia E Kurepina; Barry N Kreiswirth
Journal:  Trends Microbiol       Date:  2002-01       Impact factor: 17.079

2.  Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa.

Authors:  E M Streicher; R M Warren; C Kewley; J Simpson; N Rastogi; C Sola; G D van der Spuy; P D van Helden; T C Victor
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia.

Authors:  Igor Mokrousov; Olga Narvskaya; Tatiana Otten; Anna Vyazovaya; Elena Limeschenko; Lidia Steklova; Boris Vyshnevskyi
Journal:  Res Microbiol       Date:  2002-12       Impact factor: 3.992

4.  Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Authors:  Emma Huitric; Jim Werngren; Pontus Juréen; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease.

Authors:  M Hanekom; G D van der Spuy; E Streicher; S L Ndabambi; C R E McEvoy; M Kidd; N Beyers; T C Victor; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

6.  Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.

Authors:  Olga S Toungoussova; Andrey Mariandyshev; Gunnar Bjune; Per Sandven; Dominique A Caugant
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

7.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

8.  Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.

Authors:  G P Morlock; B B Plikaytis; J T Crawford
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

9.  Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family.

Authors:  Mina Ebrahimi-Rad; Pablo Bifani; Carlos Martin; Kristin Kremer; Sofia Samper; Jean Rauzier; Barry Kreiswirth; Jesus Blazquez; Marc Jouan; Dick van Soolingen; Brigitte Gicquel
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

10.  Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review.

Authors:  Judith R Glynn; Jennifer Whiteley; Pablo J Bifani; Kristin Kremer; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883
View more
  33 in total

1.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

3.  Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  E M Streicher; S L Sampson; K Dheda; T Dolby; J A Simpson; T C Victor; N C Gey van Pittius; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

Review 4.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors:  Christopher Dye
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

5.  Population structure dynamics of Mycobacterium tuberculosis Beijing strains during past decades in Japan.

Authors:  Tomotada Iwamoto; Riyo Fujiyama; Shiomi Yoshida; Takayuki Wada; Chika Shirai; Yasuto Kawakami
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

6.  Compensation of fitness costs and reversibility of antibiotic resistance mutations.

Authors:  Pia Schulz zur Wiesch; Jan Engelstädter; Sebastian Bonhoeffer
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

7.  Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.

Authors:  Sanjib Mani Regmi; Angkana Chaiprasert; Supasak Kulawonganunchai; Sissades Tongsima; Olabisi Oluwabukola Coker; Therdsak Prammananan; Wasna Viratyosin; Iyarit Thaipisuttikul
Journal:  Mol Genet Genomics       Date:  2015-04-24       Impact factor: 3.291

8.  Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.

Authors:  Ben J Marais; Charmaine K Mlambo; Nalin Rastogi; Thierry Zozio; Adriano G Duse; Thomas C Victor; Else Marais; Robin M Warren
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

9.  Strong Environment-Genotype Interactions Determine the Fitness Costs of Antibiotic Resistance In Vitro and in an Insect Model of Infection.

Authors:  C James Manktelow; Elitsa Penkova; Lucy Scott; Andrew C Matthews; Ben Raymond
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

10.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.